Ovarian cancer subtypes. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy9

Cell Line, Tumor Neoplastic Stem Cells Tumor Cells, Cultured Ovary Epithelial Cells Breast Cell Line Spheroids, Cellular Ascitic Fluid

Organisms3

Mice, Nude Mice, SCID Mice, Inbred BALB C

Diseases55

Ovarian Neoplasms Breast Neoplasms Neoplasms, Glandular and Epithelial Cystadenocarcinoma, Serous Carcinoma Neoplasm Invasiveness Neoplasms Neoplasms, Basal Cell Triple Negative Breast Neoplasms Lung Neoplasms Neoplasm Metastasis Genetic Predisposition to Disease Carcinoma, Lobular Adenocarcinoma, Clear Cell Carcinoma, Endometrioid Disease Progression Adenocarcinoma, Mucinous Adenocarcinoma Peritoneal Neoplasms Prostatic Neoplasms Carcinoma, Ductal, Breast Ascites Neoplasms, Hormone-Dependent Colonic Neoplasms Stomach Neoplasms Carcinoma, Squamous Cell Neoplasm Recurrence, Local Cystadenocarcinoma Endometrial Neoplasms Pancreatic Neoplasms Fallopian Tube Neoplasms Uterine Cervical Neoplasms Neoplasms, Cystic, Mucinous, and Serous Mammary Neoplasms, Experimental Neoplastic Syndromes, Hereditary Genital Neoplasms, Female Cell Transformation, Neoplastic Colorectal Neoplasms Hereditary Breast and Ovarian Cancer Syndrome Cystadenocarcinoma, Mucinous Carcinoma, Non-Small-Cell Lung Neovascularization, Pathologic Urinary Bladder Neoplasms Cystadenoma, Serous Adenocarcinoma, Papillary Rectal Neoplasms Breast Neoplasms, Male Neoplasms, Multiple Primary Disease Models, Animal Neoplasms, Second Primary Esophageal Neoplasms Lymphatic Metastasis Liver Neoplasms Cystadenocarcinoma, Papillary Precancerous Conditions

Chemicals and Drugs56

Receptors, Progesterone Receptors, Estrogen Receptor, erbB-2 Tumor Markers, Biological CA-125 Antigen Antineoplastic Agents Neoplasm Proteins Cisplatin Paclitaxel RNA, Messenger BRCA2 Protein BRCA1 Protein Tumor Suppressor Protein p53 Keratin-5 Antigens, CD24 Carboplatin Antineoplastic Agents, Phytogenic Receptor, Epidermal Growth Factor Epididymal Secretory Proteins DNA, Neoplasm Cancer Vaccines RNA, Small Interfering Antigens, Neoplasm Platinum Compounds Platinum Antibodies, Monoclonal Topotecan Transcription Factors RNA, Neoplasm Antigens, Tumor-Associated, Carbohydrate MicroRNAs Taxoids Tumor Suppressor Proteins DNA-Binding Proteins Organoplatinum Compounds Tamoxifen Proto-Oncogene Proteins c-akt Nuclear Proteins Proto-Oncogene Proteins Altretamine Contraceptives, Oral DNA Primers Antineoplastic Agents, Hormonal Prostate-Specific Antigen Fluorouracil Deoxycytidine Antibodies, Monoclonal, Humanized Folate Receptor 1 Mucin-1 Estrogens Anticarcinogenic Agents Membrane Proteins Antimetabolites, Antineoplastic GPI-Linked Proteins Antibiotics, Antineoplastic Antibodies, Neoplasm

Analytical, Diagnostic and Therapeutic Techniques and Equipment67

Gene Expression Profiling Prognosis Neoplasm Staging Early Detection of Cancer Oligonucleotide Array Sequence Analysis Cluster Analysis Survival Analysis Neoplasm Grading Immunohistochemistry Risk Factors Tissue Array Analysis Reverse Transcriptase Polymerase Chain Reaction Survival Rate Disease-Free Survival Kaplan-Meier Estimate Case-Control Studies Antineoplastic Combined Chemotherapy Protocols Xenograft Model Antitumor Assays Retrospective Studies Odds Ratio Registries Prospective Studies Risk Assessment Molecular Targeted Therapy Chemotherapy, Adjuvant Cohort Studies Incidence Reproducibility of Results Risk Blotting, Western Treatment Outcome Follow-Up Studies Logistic Models Neoplasm Transplantation Genetic Testing Sensitivity and Specificity Proportional Hazards Models Polymerase Chain Reaction Models, Biological Transplantation, Heterologous Combined Modality Therapy Mammary Neoplasms, Experimental Drug Screening Assays, Antitumor Transfection Multivariate Analysis Tumor Burden DNA Mutational Analysis Drug Administration Schedule Predictive Value of Tests Models, Statistical Questionnaires Flow Cytometry Immunoenzyme Techniques Neoadjuvant Therapy Gene Knockdown Techniques SEER Program Confidence Intervals Clinical Trials as Topic Salpingectomy Enzyme-Linked Immunosorbent Assay Mammography Disease Models, Animal Genetic Therapy Ovariectomy Reproductive History Sterilization, Tubal Immunotherapy

Psychiatry and Psychology1

Phenomena and Processes52

Gene Expression Regulation, Neoplastic Genes, BRCA1 Drug Resistance, Neoplasm Genetic Predisposition to Disease Mutation Genes, BRCA2 Genes, Neoplasm Cell Proliferation DNA Methylation Signal Transduction Odds Ratio Genes, erbB-2 Germ-Line Mutation Algorithms Risk Gene Expression Apoptosis Genotype Phenotype DNA Copy Number Variations Gene Regulatory Networks Transcriptome Cell Survival Sensitivity and Specificity Dose-Response Relationship, Drug Cell Movement Down-Regulation Transfection Cell Growth Processes Cell Division Base Sequence Up-Regulation Polymorphism, Genetic Genes, Tumor Suppressor Cell Cycle RNA Interference Promoter Regions, Genetic Gene Silencing Heterozygote Time Factors Drug Synergism Alleles Genes, p53 Phosphorylation Loss of Heterozygosity Postmenopause Tumor Microenvironment Amino Acid Sequence Parity Gene Amplification Menopause Diet

Disciplines and Occupations5

Immunohistochemistry Computational Biology Medical Oncology Genomics Genetic Counseling

Anthropology, Education, Sociology and Social Phenomena2

National Cancer Institute (U.S.)Quality of Life

Humanities1

Quality of Life

Information Science9

Survival Rate Registries Incidence Algorithms Molecular Sequence Data Base Sequence Questionnaires SEER Program Amino Acid Sequence

Named Groups3

European Continental Ancestry Group Survivors Jews

Health Care35

Cluster Analysis Survival Analysis Risk Factors Survival Rate Disease-Free Survival Kaplan-Meier Estimate Case-Control Studies Retrospective Studies Odds Ratio Registries Prospective Studies Risk Assessment Age Factors Cohort Studies Incidence Reproducibility of Results Risk Treatment Outcome Follow-Up Studies Logistic Models Genetic Testing Sensitivity and Specificity Proportional Hazards Models Multivariate Analysis National Cancer Institute (U.S.)Predictive Value of Tests Models, Statistical Questionnaires SEER Program Confidence Intervals Clinical Trials as Topic Genetic Counseling Family Health Parity Reproductive History

Geographicals3

United States California China

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Information Science Named Groups Health Care Geographicals

Ovarian Neoplasms Breast Neoplasms Neoplasms, Glandular and Epithelial Receptors, Progesterone Receptors, Estrogen Receptor, erbB-2 Gene Expression Regulation, Neoplastic Tumor Markers, Biological Gene Expression Profiling Cell Line, Tumor CA-125 Antigen Genes, BRCA1 Cystadenocarcinoma, Serous Prognosis Carcinoma Neoplasm Invasiveness Neoplasm Staging Neoplasms Early Detection of Cancer Oligonucleotide Array Sequence Analysis Drug Resistance, Neoplasm Cluster Analysis Antineoplastic Agents Neoplasms, Basal Cell Triple Negative Breast Neoplasms Survival Analysis Lung Neoplasms Neoplasm Metastasis Neoplasm Grading Immunohistochemistry Neoplasm Proteins Genetic Predisposition to Disease Carcinoma, Lobular Risk Factors Mice, Nude Adenocarcinoma, Clear Cell Tissue Array Analysis Reverse Transcriptase Polymerase Chain Reaction Mutation Genes, BRCA2 Cisplatin Paclitaxel Genes, Neoplasm Survival Rate Disease-Free Survival Cell Proliferation RNA, Messenger Carcinoma, Endometrioid BRCA2 Protein Disease Progression Neoplastic Stem Cells Kaplan-Meier Estimate BRCA1 Protein Adenocarcinoma, Mucinous Adenocarcinoma Peritoneal Neoplasms Case-Control Studies Antineoplastic Combined Chemotherapy Protocols Prostatic Neoplasms Tumor Suppressor Protein p53 Carcinoma, Ductal, Breast Ascites DNA Methylation Signal Transduction Xenograft Model Antitumor Assays Retrospective Studies Odds Ratio Registries Prospective Studies Risk Assessment Age Factors Genes, erbB-2 Molecular Targeted Therapy Chemotherapy, Adjuvant Neoplasms, Hormone-Dependent Colonic Neoplasms Keratin-5 Tumor Cells, Cultured Stomach Neoplasms Carcinoma, Squamous Cell Antigens, CD24 Cohort Studies Incidence Germ-Line Mutation Carboplatin Reproducibility of Results United States Algorithms Antineoplastic Agents, Phytogenic Neoplasm Recurrence, Local Receptor, Epidermal Growth Factor Epididymal Secretory Proteins Cystadenocarcinoma Risk Endometrial Neoplasms Blotting, Western Treatment Outcome DNA, Neoplasm Gene Expression Apoptosis

No FAQ available that match "ovarian cancer subtypes"